Advertisement

Lessons Learned in Value-Based Contracts

Interest in value-based contracts continues to grow, but the most of these arrangements are not publicly known. A survey of 11 pharmaceutical manufacturers and...

A Program Example to Combat Opioid Misuse and Abuse

The United States comprises approximately 4.4% of the global population but consumes 80% of opioids worldwide, and the majority of misuse comes from legally...

Challenges, Goals, and Strategies for the Management of Depression

Major depressive disorder is a complex, chronic, and recurrent illness that can affect other medical conditions. It is projected that 16.2 million Americans live...

Past, Present, and Future of Hemophilia Care

Despite affecting only about 20,000 people, hemophilia ranks as one of the most expensive chronic diseases in the United States, with treatment costs as...

A Look at Gene Therapies in Development

Gene therapy involves the administration of genetic material to modify or manipulate the expression of genes or alter the biological properties of living cells....

The Value of Using Pharmacogenetic Risk Scores in Routine Practice

Conducting genetic tests for variants of drug metabolizing enzyme (DME) is a potential option for personalizing medication prescribing, optimizing patient outcomes, and reducing healthcare...

Hemophilia Care From the Payer Perspective

Hemophilia is a costly and complex disease, and while there has been “incredible growth” in treatment options—48 products are currently on the market—the increased...

CAR-T, CRISPR, and More Updates in Cancer Care and How to Pay for Them

Cancer remains a leading cause of morbidity and mortality in the United States, and the cost of cancer care is projected to reach $156...

Both Chronic and Acute Opioid Users Have Increased Healthcare Utilization

Between 2000 and 2015, deaths from opioid prescriptions more than quadrupled, and evidence of long-term efficacy of opioids for chronic pain is limited. Researchers...

Hemophilia Care: A Future for Gene Therapy?

The first gene therapy trial conducted in 1990 generated big headlines until it was reported in 1999 that a participant in one of the...
Advertisement